UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Breast surgery – where do we go?

Breast (Edinburgh), 2021-04, Vol.56, p.S2

Gnant, M.

2021

Volltextzugriff (PDF)

Estimating the benefits of therapy for early-stage breast cancer: the St. Gallen International Consensus Guidelines for the primary therapy of early breast cancer 2019

Annals of oncology, 2019-10, Vol.30 (10), p.1541-1557

2019

Volltextzugriff (PDF)

Role of bisphosphonates and denosumab in the adjuvant setting

Breast (Edinburgh), 2017-03, Vol.32, p.S21-S21

Gnant, M

2017

Volltextzugriff (PDF)

Effects of Bone-Targeted Agents on Cancer Progression and Mortality

JNCI : Journal of the National Cancer Institute, 2012-07, Vol.104 (14), p.1059-1067

2012

Volltextzugriff (PDF)

Independent validation of stromal uPA in ABCSG-08: Level 1b evidence for the prognostic value of uPA immunohistochemistry

Breast (Edinburgh), 2022-08, Vol.64, p.127-133

2022

Volltextzugriff (PDF)

Zoledronic acid combined with adjuvant endocrine therapy of tamoxifen versus anastrozol plus ovarian function suppression in premenopausal early breast cancer: final analysis of the Austrian Breast and Colorectal Cancer Study Group Trial 12

Annals of oncology, 2015-02, Vol.26 (2), p.313-320

2015

Volltextzugriff (PDF)

EndoPredict improves the prognostic classification derived from common clinical guidelines in ER-positive, HER2-negative early breast cancer

Annals of oncology, 2013-03, Vol.24 (3), p.640-647

2013

Volltextzugriff (PDF)

Everolimus plus exemestane for hormone-receptor-positive, human epidermal growth factor receptor-2-negative advanced breast cancer: overall survival results from BOLERO-2

Annals of oncology, 2014-12, Vol.25 (12), p.2357-2362

2014

Volltextzugriff (PDF)

Bisphosphonates in the prevention of disease recurrence: current results and ongoing trials

Current cancer drug targets, 2009-11, Vol.9 (7), p.824-833

Gnant, M

2009

Volltextzugriff (PDF)

Predicting distant recurrence in receptor-positive breast cancer patients with limited clinicopathological risk: using the PAM50 Risk of Recurrence score in 1478 postmenopausal patients of the ABCSG-8 trial treated with adjuvant endocrine therapy alone

Annals of oncology, 2014-02, Vol.25 (2), p.339-345

2014

Volltextzugriff (PDF)

Randomized clinical trial of the effect of a fibrin sealant patch on pancreatic fistula formation after pancreatoduodenectomy

British journal of surgery, 2018-06, Vol.105 (7), p.811-819

2018

Volltextzugriff (PDF)

Identifying clinically relevant prognostic subgroups of postmenopausal women with node-positive hormone receptor-positive early-stage breast cancer treated with endocrine therapy: a combined analysis of ABCSG-8 and ATAC using the PAM50 risk of recurrence score and intrinsic subtype

Annals of oncology, 2015-08, Vol.26 (8), p.1685-1691

2015

Volltextzugriff (PDF)

Management of aromatase inhibitor-associated bone loss in postmenopausal women with breast cancer: practical guidance for prevention and treatment

Annals of oncology, 2011-12, Vol.22 (12), p.2546-2555

2011

Volltextzugriff (PDF)

PG 4.03 Targeting bone microenvironment: clinical implications

Breast (Edinburgh), 2015-03, Vol.24, p.S8-S9

Gnant, M

2015

Volltextzugriff (PDF)

The EndoPredict score provides prognostic information on late distant metastases in ER+/HER2− breast cancer patients

British journal of cancer, 2013-12, Vol.109 (12), p.2959-2964

2013

Volltextzugriff (PDF)

Abstract DEB1-1: Pro - RxPONDER: Was it all OFS?

Cancer research (Chicago, Ill.), 2022-02, Vol.82 (4_Supplement), p.DEB1-1-DEB1-1

Gnant, M

2022

Volltextzugriff (PDF)

Guidance on the use of bisphosphonates in solid tumours: recommendations of an international expert panel

Annals of oncology, 2008-03, Vol.19 (3), p.420-432

2008

Volltextzugriff (PDF)

PAM-50 predicts local recurrence after breast cancer surgery in postmenopausal patients with ER+/HER2- disease: results from 1204 patients in the randomized ABCSG-8 trial

British journal of surgery, 2021-04, Vol.108 (3), p.308-314

2021

Volltextzugriff (PDF)

Adjuvant bisphosphonates in early breast cancer: consensus guidance for clinical practice from a European Panel

Annals of oncology, 2016-03, Vol.27 (3), p.379-390

2016

Volltextzugriff (PDF)

De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017

Annals of oncology, 2019-07, Vol.30 (7), p.1181-1181

2019

Volltextzugriff (PDF)

The impact of menopause on bone, zoledronic acid, and implications for breast cancer growth and metastasis

Annals of oncology, 2012-11, Vol.23 (11), p.2782-2790

2012

Volltextzugriff (PDF)

Incidence and time course of everolimus-related adverse events in postmenopausal women with hormone receptor-positive advanced breast cancer: insights from BOLERO-2

Annals of oncology, 2014-04, Vol.25 (4), p.808-815

2014

Volltextzugriff (PDF)

The genomic expression test EndoPredict is a prognostic tool for identifying risk of local recurrence in postmenopausal endocrine receptor-positive, her2neu-negative breast cancer patients randomised within the prospective ABCSG 8 trial

British journal of cancer, 2015-04, Vol.112 (8), p.1405-1410

2015

Volltextzugriff (PDF)

ERRα promotes breast cancer cell dissemination to bone by increasing RANK expression in primary breast tumors

Oncogene, 2019-02, Vol.38 (7), p.950-964

2019

Volltextzugriff (PDF)

The AURORA initiative for metastatic breast cancer

British journal of cancer, 2014-11, Vol.111 (10), p.1881-1887

2014

Volltextzugriff (PDF)

1 – 25 von 565

Suche als RSS-Feed

Aktive Filter

PublikationsformArtikel

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(545)
Mit Volltextzugriff
(495)

Sprache

Englisch
(540)
Deutsch
(25)
Japanisch
(2)
Russisch
(1)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(257)
Science & Technology
(257)
Humans
(248)
Female
(207)
Oncology
(180)
Middle Aged
(134)
Biological And Medical Sciences
(131)
Medical Sciences
(130)
Adult
(106)
Aged
(106)
Breast Cancer
(105)
Tumors
(99)
Breast Neoplasms - Pathology
(92)
Breast Neoplasms - Drug Therapy
(91)
Surgery
(67)
Gynecology. Andrology. Obstetrics
(63)
Mammary Gland Diseases
(63)
Pharmacology. Drug Treatments
(56)
Hematology, Oncology And Palliative Medicine
(51)
Male
(51)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Annals Of Oncology
(69)
Cancer Research
(63)
Journal Of Clinical Oncology
(51)
European Journal Of Cancer
(45)
Breast
(30)
Transplantation Proceedings
(20)
British Journal Of Cancer
(18)
Breast Cancer Research And Treatment
(16)
Clinical Cancer Research
(16)
European Surgery
(16)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Breast surgery – where do we go?

Estimating the benefits of therapy for early-stage breast cancer: the St. Gallen International Consensus Guidelines for the primary therapy of early breast cancer 2019

Role of bisphosphonates and denosumab in the adjuvant setting

Effects of Bone-Targeted Agents on Cancer Progression and Mortality

Independent validation of stromal uPA in ABCSG-08: Level 1b evidence for the prognostic value of uPA immunohistochemistry

Zoledronic acid combined with adjuvant endocrine therapy of tamoxifen versus anastrozol plus ovarian function suppression in premenopausal early breast cancer: final analysis of the Austrian Breast and Colorectal Cancer Study Group Trial 12

EndoPredict improves the prognostic classification derived from common clinical guidelines in ER-positive, HER2-negative early breast cancer

Everolimus plus exemestane for hormone-receptor-positive, human epidermal growth factor receptor-2-negative advanced breast cancer: overall survival results from BOLERO-2

Bisphosphonates in the prevention of disease recurrence: current results and ongoing trials

Predicting distant recurrence in receptor-positive breast cancer patients with limited clinicopathological risk: using the PAM50 Risk of Recurrence score in 1478 postmenopausal patients of the ABCSG-8 trial treated with adjuvant endocrine therapy alone

Randomized clinical trial of the effect of a fibrin sealant patch on pancreatic fistula formation after pancreatoduodenectomy

Identifying clinically relevant prognostic subgroups of postmenopausal women with node-positive hormone receptor-positive early-stage breast cancer treated with endocrine therapy: a combined analysis of ABCSG-8 and ATAC using the PAM50 risk of recurrence score and intrinsic subtype

Management of aromatase inhibitor-associated bone loss in postmenopausal women with breast cancer: practical guidance for prevention and treatment

PG 4.03 Targeting bone microenvironment: clinical implications

The EndoPredict score provides prognostic information on late distant metastases in ER+/HER2− breast cancer patients

Abstract DEB1-1: Pro - RxPONDER: Was it all OFS?

Guidance on the use of bisphosphonates in solid tumours: recommendations of an international expert panel

PAM-50 predicts local recurrence after breast cancer surgery in postmenopausal patients with ER+/HER2- disease: results from 1204 patients in the randomized ABCSG-8 trial

Adjuvant bisphosphonates in early breast cancer: consensus guidance for clinical practice from a European Panel

De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017

The impact of menopause on bone, zoledronic acid, and implications for breast cancer growth and metastasis

Incidence and time course of everolimus-related adverse events in postmenopausal women with hormone receptor-positive advanced breast cancer: insights from BOLERO-2

The genomic expression test EndoPredict is a prognostic tool for identifying risk of local recurrence in postmenopausal endocrine receptor-positive, her2neu-negative breast cancer patients randomised within the prospective ABCSG 8 trial

ERRα promotes breast cancer cell dissemination to bone by increasing RANK expression in primary breast tumors

The AURORA initiative for metastatic breast cancer

Aktive Filter

Suchergebnisse filtern